BioMedSA New Members: October 2026

The START Center for Cancer Research conducts the most early-phase oncology trials in the world, conducting more than 1,000 studies and contributing to the development of over 50 FDA- or EMA-approved cancer therapies. Through its extensive network of community-based research sites and investigators, START accelerates access to innovative cancer treatments worldwide.  Their mission goes beyond … Read more

BioMedSA New Members: May 2026

BioMedSA’s Board of Directors approved 2 new memberships in April 2026:  Bartlett Cocke General Contractors and Cizzle Bio. Bartlett Cocke General Contractors is a Texas‑based construction firm recognized for its extensive work in healthcare and clinical environments. The company has delivered a wide range of medical facilities, including hospitals, imaging centers, surgical suites, and specialized … Read more

BioMedSA New Members: March 2026

BioMedSA’s Board of Directors approved 2 new members in March 2026: Eich, Inc. and Integral LifeScience Advisors. Integral LifeScience Advisors is a consulting firm that supports life‑science and healthcare companies across multiple stages of development. The firm provides medical and clinical expertise, including clinical development planning, evidence generation strategy, and support for interactions with healthcare stakeholders. … Read more

Login

Welcome back! Login below